Update on COVID Vaccinations 10/03/2021

As we continue to deliver COVID vaccinations through Mill Road Surgery and the Primary Care Vaccination Centre, we would like to thank our wonderful staff and dedicated volunteers without whom delivering this fantastic local service would have been impossible, they have worked tirelessly since the roll out of the programme in December, even in adverse weather conditions. Thank you also to our patients for a near 100% turnout making the vaccination drive a success.

We are moving through the cohorts as advised by the government and will be inviting patients through a texting service asking them to book their appointment online. If you receive a text asking you to book a vaccination please use this, there is no need to phone the surgery. A text from the surgery would be worded as follows – “Dear Patient name. You have been invited to book your first (or second) COVID-19 vaccination. Please click on the link to book: accurx.thirdparty.nhs.uk/*****.  Thanks’ Mill Road Sugery”.

A genuine text will never ask you for your bank details and you should not respond to such fraudulent texts.

Please do not telephone the surgery to ask if the text is a spam, it is from the surgery. Please book your appointment as soon as you can to ensure you get your appointment. Only call us if you receive a text and do not have means to book the appointment online. Patient who don’t have a mobile phone will be called by our staff to make their appointment. We review our list of invitees and if anyone has not responded, we will ring them to make appointments. You may also receive an invite from a government agency to book at the stadium or the hospital and you are free to book which ever service you prefer. If you feel you may have been missed and are eligible then please do contact us to clarify.

We have been receiving both Pfizer and Astra Zeneca vaccines, unfortunately we are not able to offer a choice and you will be offered the vaccine that is being offered on the day. You will then be contacted in the future when the second dose becomes available.

There are only a very very small group of patients who may not be able to have the vaccine- those with a previous history of allergic reactions to the ingredients(see below for list) of the vaccine or anaphylactic reaction to first dose of the vaccine should not receive it, but those with any other allergies -such as a food /most medicine allergies/ family history of allergies/insect sting allergy/rashes or fainting after vaccines can now have the Pfizer or AZ vaccine. Your vaccinator will check any contraindications before giving you the jab.

Minor illnesses are not a valid reason to postpone immunisation but if you are very unwell with high temperature, immunisation may be postponed until you have fully recovered.

Individuals experiencing symptoms of COVID-19 disease should not attend for vaccination until they have recovered. This is to avoid wrongly attributing any new symptom or the progression of symptoms to the vaccine and infecting others at the vaccination centre. Vaccination should ideally be deferred until around 4 weeks after onset of symptoms, or from the first positive test in those who are asymptomatic.

Those with a previous history of COVID-19 disease (whether confirmed or suspected) can still receive COVID-19 vaccine because it is not yet known how long antibodies made in response to natural infection persist and whether immunisation could offer more protection. Having prolonged COVID-19 symptoms (‘Long COVID’) is not a contraindication to receiving COVID-19 vaccine unless you are advised to do so by your doctor.


Although the available data do not indicate any safety concerns or harm to pregnancy, there is currently insufficient evidence to recommend the routine use of COVID-19 vaccine during pregnancy. However, government scientists have advised that vaccination in pregnancy should be considered where the risk of exposure to SARS-CoV-2 infection is high and cannot be avoided, or where the woman has underlying conditions that put them at very high risk of serious complications of COVID-19.

Those who are trying to become pregnant do not need to avoid pregnancy after vaccination. If a woman finds out she is pregnant after she has started a course of COVID-19 vaccine, she may complete vaccination during pregnancy if she is considered at high risk. Alternatively, vaccination should be offered as soon as possible after pregnancy.

Breast Feeding

There is no known risk associated with the currently used non live vaccines whilst breastfeeding.

Side Effects

In terms of side effects, in clinical trials, local reactions at the injection site were found to be fairly common. Over 80% of trial participants reported pain at the injection site. Swelling and redness at the injection site was also reported. This occurred within 7 days after the injection and resolved after a few days. Other reactions include tiredness (>60%), headache (>50%), muscle aches (>30%), chills (>30%), joint pain (>20%) and a raised temperature (>10%).

These symptoms were usually mild or moderate in intensity and resolved within a few days after vaccination. Medicines such as paracetamol can be given for post-vaccination pain or fever if required. These symptoms normally last less than a week but if your symptoms seem to get worse or you are concerned, you are advised to speak to us or call NHS 111.

Until more information is known about concomitant vaccination, it is recommended that COVID-19 vaccines are not routinely given at the same time as any other vaccine and that there should ideally be an interval of at least 7 days between COVID-19 vaccine and a different vaccine to avoid incorrect attribution of potential adverse events.

The COVID-19 Vaccine AstraZeneca components :

  • L-Histidine
  • L-Histidine hydrochloride monohydrate
  • Magnesium chloride hexahydrate
  • Polysorbate 80
  • Ethanol
  • Sucrose
  • Sodium chloride
  • Disodium edetate dihydrate
  • Water for injections

COVID-19 mRNA Vaccine BNT162b2 components

  • Polyethylene glycol (PEG)
  • ALC-0315 = (4-hydroxybutyl) azanediyl)bis (hexane-6,1-diyl)bis(2-hexyldecanoate)
  • ALC-0159 = 2-[(polyethylene glycol)-2000]-N,N-ditetradecylacetamide
  • 1,2-Distearoyl-sn-glycero-3-phosphocholine
  • Cholesterol
  • Potassium chloride
  • Potassium dihydrogen phosphate
  • Sodium chloride
  • Disodium hydrogen phosphate dihydrate
  • Sucrose
  • Water for injections